Efficacy and Saftey Study of 99mTc-ECDG in the Evaluation of Coronary Artery Disease (CAD)

NCT01899833 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DIAGNOSTIC_TEST: 99mTc-Sestamibi

Sponsor

Cell>Point LLC